A Bangladeshi pharmaceutical company has struck a deal with the Serum Institute of India (SII) to gain priority access to Covid-19 vaccines being developed by the world’s largest drug manufacturer. Pune-based Serum Institute, in partnership with AstraZeneca, the Gates Foundation, and the Gavi Vaccine Alliance, will produce 1 billion doses …
Read More »After the Covid-19 vaccine deal with China, the Bangladeshi company now signs a pact with India’s IBS
